Share chart Oragenics, Inc.
Extended chart
Simple chart
About Oragenics, Inc.
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. more details| IPO date | 2004-02-25 |
|---|---|
| ISIN | US6840233026 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.oragenics.com |
| Цена ао | 0.2462 |
| Change price per day: | -7.65% (0.234) |
|---|---|
| Change price per week: | -16.88% (0.26) |
| Change price per month: | -22.82% (0.28) |
| Change price per 3 month: | -52.35% (0.4535) |
| Change price per half year: | -43.31% (0.3812) |
| Change price per year: | -84.99% (1.44) |
| Change price per 3 year: | -39.64% (0.358) |
| Change price per 5 year: | -58.95% (0.5264) |
| Change price per year to date: | -42.83% (0.378) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Charles L. Pope CPA | Executive Chairman | 1952 (73 years) | |
| Mr. Joseph Michael Redmond | President & Interim Principal Executive Officer | 1961 (64 years) | |
| Ms. Janet Huffman | CFO, Secretary & Treasurer | 1972 (53 years) | |
| Dr. James P. Kelly M.A., M.D. | Chief Medical Officer & Member of Scientific Advisor | ||
| Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D. | Chief Clinical Officer |
Address: United States, Tampa, 4902 Eisenhower Boulevard - open in Google maps, open in Yandex maps
Website: https://www.oragenics.com
Website: https://www.oragenics.com
